论文部分内容阅读
At the Wellcome Trust Sanger Institute we aim to produce in excess of 250 unique genetically modified mouse lines from the IKMC resource of C57BL/6N targeted ES cells for our primary and secondary phenotyping pipelines (Mouse Genetics Project MGP and KOMP2 BaSH consortia).